chartexchange

ZVRA
Zevra Therapeutics, Inc. Common Stock
stockNASDAQ

Market OpenNov 19, 2026 3:26:31 PM EST
9.01USD-2.909%(-0.27)370,852
Pre-marketNov 19, 2026 9:11:30 AM EST
9.43USD+1.616%(+0.15)
9.0000Bid9.3800Ask0.3800Spread
Loading…
Loading…
536.43M
Healthcare
Biotechnology
HQ
Celebration, FL, USA
Previous Close
$9.28
Beta
1.03
52-Week High
$15.04 2026-07-08
52-Week Low
$8.01 2025-12-19
SMA 50
$10.80
SMA 200
$10.85
Avg. Vol 10D
1.39M
Avg. Vol 30D
967,482
Avg. Vol 90D
1.06M
Relative Vol
0.38
53.99M
0.3500%
1,400,000
153
ZVRA Profile

kempharm is a biopharmaceutical company focused on the discovery and development of new chemical entities (nces) to treat serious medical conditions through its proprietary and broadly applicable ligand activated therapy (lat) approach. the company utilizes its lat technology to generate improved prodrug versions of fda approved drugs in the high needs areas of pain, adhd and other cns diseases.

ZVRA Performance
PeriodPriceDateChangeBeta
1W11.162026-11-12-19.22%-7.645
1M10.162026-10-19-11.27%1.607
3M12.132026-08-19-25.68%1.459
6M10.202026-05-19-11.62%0.914
1Y9.682025-11-19-6.87%1.031
2Y8.972024-11-19+0.50%—
5Y5.332023-03-02+69.14%0.434
ZVRA Stock Summary

Zevra Therapeutics, Inc. Common Stock (NASDAQ:ZVRA) stock price today is $9.02, and today's volume is 369,740. ZVRA is down 2.856% today. The 30 day average volume is 967,482. ZVRA market cap is $536.43M with 59.50M shares outstanding.